ติดตาม
Paul W Armstrong
Paul W Armstrong
professor medicine university alberta
ยืนยันอีเมลแล้วที่ ualberta.ca
ชื่อ
อ้างโดย
อ้างโดย
ปี
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 133 (4), e38-e360, 2016
83017*2016
Third universal definition of myocardial infarction
K Thygesen, JS Alpert, AS Jaffe, ML Simoons, BR Chaitman, HD White
circulation 126 (16), 2020-2035, 2012
19139*2012
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary: a report of the American College of Cardiology/American Heart …
Writing Committee Members, EM Antman, DT Anbe, PW Armstrong, ...
Journal of the American College of Cardiology 44 (3), 671-719, 2004
9826*2004
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
Gusto Investigators
New England Journal of Medicine 329 (10), 673-682, 1993
48101993
Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes
JB Green, MA Bethel, PW Armstrong, JB Buse, SS Engel, J Garg, R Josse, ...
New England Journal of Medicine 373 (3), 232-242, 2015
32902015
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
Epic Investigators
New England Journal of Medicine 330 (14), 956-961, 1994
30151994
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article: a report of the American …
E Braunwald, EM Antman, JW Beasley, RM Califf, MD Cheitlin, ...
Journal of the American College of Cardiology 40 (7), 1366-1374, 2002
27182002
The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
GUSTO Angiographic Investigators
New England Journal of Medicine 329 (22), 1615-1622, 1993
21561993
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure
M Packer, PA Poole-Wilson, PW Armstrong, JGF Cleland, JD Horowitz, ...
Circulation 100 (23), 2312-2318, 1999
18711999
Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
PURSUIT Trial Investigators
New England Journal of Medicine 339 (7), 436-443, 1998
16971998
Cardiac troponin T levels for risk stratification in acute myocardial ischemia
EM Ohman, PW Armstrong, RH Christenson, CB Granger, HA Katus, ...
New England Journal of Medicine 335 (18), 1333-1342, 1996
15211996
Effect of nesiritide in patients with acute decompensated heart failure
CM O'Connor, RC Starling, AF Hernandez, PW Armstrong, K Dickstein, ...
New England Journal of Medicine 365 (1), 32-43, 2011
14962011
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials
E Boersma, RA Harrington, DJ Moliterno, H White, P Théroux, ...
The Lancet 359 (9302), 189-198, 2002
14472002
Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure
JA Ezekowitz, FA McAlister, PW Armstrong
Circulation 107 (2), 223-225, 2003
13792003
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: results from an international trial of 9461 patients
E Boersma, KS Pieper, EW Steyerberg, RG Wilcox, WC Chang, KL Lee, ...
Circulation 101 (22), 2557-2567, 2000
13702000
Vericiguat in patients with heart failure and reduced ejection fraction
PW Armstrong, B Pieske, KJ Anstrom, J Ezekowitz, AF Hernandez, ...
New England Journal of Medicine 382 (20), 1883-1893, 2020
12652020
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes
SV Rao, JG Jollis, RA Harrington, CB Granger, LK Newby, PW Armstrong, ...
Jama 292 (13), 1555-1562, 2004
12562004
Acute coronary care in the elderly, part I: non–ST-segment–elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart …
KP Alexander, LK Newby, CP Cannon, PW Armstrong, WB Gibler, ...
Circulation 115 (19), 2549-2569, 2007
1252*2007
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction
PW Armstrong, AH Gershlick, P Goldstein, R Wilcox, T Danays, Y Lambert, ...
New England Journal of Medicine 368 (15), 1379-1387, 2013
12052013
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
MT Roe, PW Armstrong, KAA Fox, HD White, D Prabhakaran, ...
New England journal of medicine 367 (14), 1297-1309, 2012
11122012
ระบบไม่สามารถดำเนินการได้ในขณะนี้ โปรดลองใหม่อีกครั้งในภายหลัง
บทความ 1–20